Eplerenone With Valsartan Effectively Reduces Atherosclerotic Lesion by Attenuation of Oxidative Stress and Inflammation
- 1 April 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (4) , 917-921
Abstract
Objective— Angiotensin II contributes to atherogenesis, mainly through oxidative stress and inflammation. Recent data suggest that aldosterone is implicated in some effects of angiotensin II. We hypothesized that aldosterone could directly contribute to oxidative stress and atherosclerotic lesion formation. Methods and Results— Male apolipoprotein E–deficient mice 6 weeks of age were placed on a normal diet or 1.25% high-cholesterol diet. After 6 weeks of the high-cholesterol diet, a marked increase in atherosclerotic lesion formation was observed in the aorta, accompanied by significant elevation of plasma cholesterol level. Production of superoxide anion and expression of NAD(P)H oxidase subunit p47 phox , tumor necrosis factor-α, and monocyte chemoattractant protein-1 in the aorta were increased with the high-cholesterol diet. Eplerenone (1.67 g/kg in high-cholesterol diet) did not affect blood pressure or plasma cholesterol but decreased the atherosclerotic area by nearly 70% ( P Conclusions— These results suggest that aldosterone may play a critical role in atherogenesis subsequent to oxidative stress in part independent of angiotensin II–mediated signaling, and that eplerenone could prevent atherosclerosis by attenuating oxidative stress and inflammation.Keywords
This publication has 20 references indexed in Scilit:
- Aldosterone and Angiotensin II Synergistically Induce Mitogenic Response in Vascular Smooth Muscle CellsCirculation Research, 2005
- Inhibition of Diet-Induced Atherosclerosis and Endothelial Dysfunction in Apolipoprotein E/Angiotensin II Type 1A Receptor Double-Knockout MiceCirculation, 2004
- Fluvastatin Enhances the Inhibitory Effects of a Selective AT 1 Receptor Blocker, Valsartan, on AtherosclerosisHypertension, 2004
- Non-genomic effects of aldosterone: new actions and questionsTrends in Endocrinology & Metabolism, 2004
- Rapid non‐genomic effects of aldosterone on rodent vascular functionActa Physiologica Scandinavica, 2004
- Aldosterone Potentiates Angiotensin II–Induced Signaling in Vascular Smooth Muscle CellsCirculation, 2004
- Oxidative Stress and Endothelial Nitric Oxide BioactivityAntioxidants & Redox Signaling, 2003
- Fluvastatin Enhances the Inhibitory Effects of a Selective Angiotensin II Type 1 Receptor Blocker, Valsartan, on Vascular Neointimal FormationCirculation, 2003
- Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice.Journal of Clinical Investigation, 1994
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992